Evidence map›Paper›PMID 38867699›Full record

ArticleBioinformatics (Oxford, England)2024

MCDHGN: heterogeneous network-based cancer driver gene prediction and interpretability analysis.

Lexiang Wang, Jingli Zhou, Xuan Wang, Yadong Wang, Junyi Li

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Pathway-guided architectures for interpretable AI in biological research.Computational and structural biotechnology journal · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lexiang WangSchool of Computer Science and Technology, Harbin Institute of Technology (Shenzhen), Shenzhen 518055, China.
Jingli ZhouSchool of Computer Science and Technology, Harbin Institute of Technology (Shenzhen), Shenzhen 518055, China.
Xuan WangSchool of Computer Science and Technology, Harbin Institute of Technology (Shenzhen), Shenzhen 518055, China.
Yadong WangCenter for Bioinformatics, Faculty of Computing, Harbin Institute of Technology, Harbin, Heilongjiang 150001, China.ORCID 0000-0001-6500-6217
Junyi LiSchool of Computer Science and Technology, Harbin Institute of Technology (Shenzhen), Shenzhen 518055, China.ORCID 0000-0001-8045-5264

Funding

Guangdong Basic and Applied Basic Research Foundation 2021A1515012461Guangdong Provincial Key Laboratory of Novel Security Intelligence Technologies 2022B1212010005National Key Research and Development Program of China 2021YFA0910700Shenzhen Science and Technology GXWD20201230155427003-20200821222112001Shenzhen Science and Technology JCYJ20200109113201726
6 · The paper itself

Abstract

motivationAccurately predicting the driver genes of cancer is of great significance for carcinogenesis progress research and cancer treatment. In recent years, more and more deep-learning-based methods have been used for predicting cancer driver genes. However, deep-learning algorithms often have black box properties and cannot interpret the output results. Here, we propose a novel cancer driver gene mining method based on heterogeneous network meta-paths (MCDHGN), which uses meta-path aggregation to enhance the interpretability of predictions.

resultsMCDHGN constructs a heterogeneous network by using several types of multi-omics data that are biologically linked to genes. And the differential probabilities of SNV, DNA methylation, and gene expression data between cancerous tissues and normal tissues are extracted as initial features of genes. Nine meta-paths are manually selected, and the representation vectors obtained by aggregating information within and across meta-path nodes are used as new features for subsequent classification and prediction tasks. By comparing with eight homogeneous and heterogeneous network models on two pan-cancer datasets, MCDHGN has better performance on AUC and AUPR values. Additionally, MCDHGN provides interpretability of predicted cancer driver genes through the varying weights of biologically meaningful meta-paths. AVAILABILITY AND IMPLEMENTATION: https://github.com/1160300611/MCDHGN.

Indexed as

NeoplasmsAlgorithmsComputational BiologyData MiningDeep LearningDNA MethylationGene Regulatory NetworksHumans

Identifiers

PMID38867699
PMCPMC11256962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.